Valleylab has announced the FDA has granted marketing clearance for the Cool-tip RF ablation system. According to the manufacturer, the system is the first and only device cleared for marketing to physicians for use in ablating nonresectable liver tumors. This minimally invasive alternative for patients with hepatic cancer, who are not ideal surgical candidates or are otherwise unable to be successfully treated with other methods, solidifies the company’s commitment to the oncology market.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now